MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, MLYS has $661,806K in assets. $172,921K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
4376.27%
Quick Ratio
4376.27%
Cash Ratio
1144.19%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investments
    • Prepaid and other current assets
    • Other assets
    • Property and equipment, net
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Common stock, 0.0001 par value 5...

Balance Sheets
2025-12-31
Cash and cash equivalents
172,921
Investments
483,714
Prepaid and other current assets
4,751
Total current assets
661,386
Property and equipment, net
38
Other assets
382
Total assets
661,806
Accounts payable
2,017
Accrued liabilities
13,096
Total current liabilities
15,113
Common stock, 0.0001 par value 500,000,000 shares authorized as of december31, 2025 and 2024 81,536,557 and 49,821,915 shares issued and outstanding as of december31, 2025 and 2024, respectively
8
Additional paid-in capital
1,103,854
Accumulated deficit
-457,169
Total stockholders equity
646,693
Total liabilities and stockholders equity
661,806
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$483,714K Cash and cashequivalents$172,921K Prepaid and othercurrent assets$4,751K Total current assets$661,386K Other assets$382K Property and equipment,net$38K Total assets$661,806K Total liabilities andstockholders equity$661,806K Total stockholdersequity$646,693K Total currentliabilities$15,113K Accumulated deficit-$457,169K Additional paid-in capital$1,103,854K Accrued liabilities$13,096K Accounts payable$2,017K Common stock, 0.0001par value...$8K

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. (MLYS)